Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Electroconvulsive Therapy for the Neuropsychiatric Manifestations of Amyostatic-Akinetic Encephalitis Lethargica: A Case Report

AI Summary
  • First reported case of encephalitis lethargica with neuropsychiatric symptoms successfully treated with electroconvulsive therapy.
  • Middle-aged male developed amyostatic-akinetic encephalitis lethargica after COVID-19 encephalitis, presenting with palilalia, ophthalmoplegia, insomnia, tachypnea, Parkinsonism, akinetic mutism.
  • Marked improvement after 4 ultrabrief pulse right unilateral electroconvulsive therapy, with symptom control maintained by 2 years of maintenance treatment.
Summarise with AI (MRCPsych/FRANZCP)

J ECT. 2026 May 26. doi: 10.1097/YCT.0000000000001278. Online ahead of print.

ABSTRACT

Encephalitis lethargica, first described in 1917 as a sequela of the Spanish flu, was characterized by a nonspecific inflammatory prodrome followed by profound sleep disturbances and chronic neurological sequelae, particularly postencephalitic Parkinsonism. Though numerous theories have been suggested to explain encephalitis lethargica, the rarity of the condition has limited formal investigations. Described here may be the first case of encephalitis lethargica in which the neuropsychiatric symptoms were successfully treated with electroconvulsive therapy. A middle-aged male, who initially presented with heterophonic palilalia following a protracted hospitalization for COVID-19 encephalitis 3 months prior, was admitted to inpatient psychiatry for a recurrence of palilalia. He rapidly deteriorated, developing extraocular ophthalmoplegia, persistent insomnia, severe intermittent tachypnea, acute Parkinsonism, and eventual akinetic mutism. He met the criteria described by Howard and Lee for encephalitis lethargica, with a presentation most consistent with the amyostatic-akinetic subtype. He failed pharmacological management but showed a marked improvement following 4 treatments with ultrabrief pulse right unilateral electroconvulsive therapy. Since discharge, his symptomatology has been controlled with 2 years of maintenance treatment.

PMID:42218820 | DOI:10.1097/YCT.0000000000001278

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review